quiz question 4 (lutonix) Flashcards
in the lutonix AV trial, what was the primary patency at 6 months for lutonix?
71.4%
identify the therapeutic drug dose of paclitaxel on the AV lutonix dcb
2 micro grams/ mm^2
what was the reduction in reinterventions at 6 months in the lutonix arm of the lutonix AV trial
31.3%
what was the observed TLPP improvement for lutonix over PTA at 24 months in the lutonix AV trial?
26.9%
In the AV lutonix trial the inclusion criteris for stenosis % was a minimum of what percentage?
50%
the medtronic IN.PACT dcb balloon has ___% more drug on the balloon than Lutonix DCB
75%
data shows slightly significant distal embolic and downstream drug effects from the lutonix 035 formulation at 4x the dose
false
in the AV lutonix trial what % of lesions were restonic
70%
in the AV lutonix dcb trial 30% of patients recieved greater than 25 atm pressure, with the mean pre-dialation pressure of 21.5 atm
true
the average half life of lutonix dcb is ____ hrs compared to ____ hrs for medtronic in-pact dcb
6.9 and 72.5
the av lutonix dcb balloon should be advanced to the lesion within ____ and the balloon should be held for _____
- 30 seconds
- 2-3 minutes
explain why global registry would be used vs. IDE information
global registry data is more “real world data”
the AV lutonix trial consisted of _____ subjects at ____ clinical sites
285 and 23
in the lutonix av trial, what was the average time to first reintervention at 24 months for the lutonix arm
114 days
what % of patients were treated in the forearm radiocephalic in the AV lutonix trial compared to the in.pact ide trial?
33.3 vs. 50.6
